{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "逐渐摆脱疫情影响，单季度业绩上扬",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-10-20 00:00:00.000",
      "infoCode": "AP202010201422485234",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 542,
      "attachPages": 3,
      "encodeUrl": "9NzypCmdc49FKCr9CLvVhXrt/nOjnROkIqSGI+wilHQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "增速稳健业绩符合预期，各项研发顺利进行",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2020-10-20 00:00:00.000",
      "infoCode": "AP202010201422484484",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321135.王麟"
      ],
      "indvIsNew": "001",
      "researcher": "王麟",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 671,
      "attachPages": 4,
      "encodeUrl": "9NzypCmdc49FKCr9CLvVhSBHLUX4GrFhv02AwN7bOx0=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321135"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司激励方案刺激新一轮中长期发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-08-19 00:00:00.000",
      "infoCode": "AP202008191399536594",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 670,
      "attachPages": 3,
      "encodeUrl": "eH0wEwzKhZfwE8XeXatG2UNKBa0cMvMTQo7gRnQbIyQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "抗肿瘤线增势不减，麻醉线短期受疫情影响，股权激励发布，保障业绩增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2020-08-04 00:00:00.000",
      "infoCode": "AP202008041396401180",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "105.0000000000",
      "indvAimPriceL": "105.0000000000",
      "attachType": "0",
      "attachSize": 273,
      "attachPages": 3,
      "encodeUrl": "x5Q6HjGoYIqcw9G5BobZCVtAWqacjFuQfsL2zBiSjI8=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "中报点评：业绩季度环比改善，股权激励注入长期发展动力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券",
      "orgSName": "中航证券",
      "publishDate": "2020-08-04 00:00:00.000",
      "infoCode": "AP202008041396354059",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 450,
      "attachPages": 3,
      "encodeUrl": "x5Q6HjGoYIqcw9G5BobZCQQh/mJWxwkyKZYKLmheUmk=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药快速增长，研发力度持续加大",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2020-08-04 00:00:00.000",
      "infoCode": "AP202008041396315605",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 595,
      "attachPages": 5,
      "encodeUrl": "x5Q6HjGoYIqcw9G5BobZCQQ+HmSJgxPhx5GRuSuYQ9w=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩受疫情影响，肿瘤产品仍强劲",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-08-03 00:00:00.000",
      "infoCode": "AP202008031396162312",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "王睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 615,
      "attachPages": 5,
      "encodeUrl": "YQRfkfJ+iPQIQ9qXe35SaWe3Kn3uMHHBL9vaudtgvSk=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000308731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药20年中报点评：疫情不改业绩恢复趋势，股权激励彰显信心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-08-03 00:00:00.000",
      "infoCode": "AP202008031396052425",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉",
        "11000309636.刘慧敏",
        "11000309635.汤芬芬",
        "11000309637.刘巧"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉,刘慧敏,汤芬芬,刘巧",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2076,
      "attachPages": 10,
      "encodeUrl": "YQRfkfJ+iPQIQ9qXe35SafWmI9ycDRETBjN25SfNRXo=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000238231",
        "11000309636",
        "11000309635",
        "11000309637"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入端增速逐步提高，研发投入持续增加",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-08-03 00:00:00.000",
      "infoCode": "AP202008031396052415",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1214,
      "attachPages": 5,
      "encodeUrl": "YQRfkfJ+iPQIQ9qXe35SaSIP80EYB5zn+o0Ve4RZ1lA=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩略低于预期，造影剂保持稳定增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-08-03 00:00:00.000",
      "infoCode": "AP202008031396011650",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 665,
      "attachPages": 3,
      "encodeUrl": "YQRfkfJ+iPQIQ9qXe35SaeEBKKun7FPkTLfADlLAgNo=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "PD-1单抗肺癌及食管癌两大适应症获批，将助力单抗销售放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券",
      "orgSName": "群益证券",
      "publishDate": "2020-06-23 00:00:00.000",
      "infoCode": "AP202006231386777060",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "105.0000000000",
      "indvAimPriceL": "105.0000000000",
      "attachType": "0",
      "attachSize": 261,
      "attachPages": 4,
      "encodeUrl": "tHYt44e41PaxNlChe9xIIfdosjuhFw+ycYnVN60kVUs=",
      "sRatingName": "买入",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2020Q1点评：疫情之下，强者恒强",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-04-28 00:00:00.000",
      "infoCode": "AP202004281378861805",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 956,
      "attachPages": 3,
      "encodeUrl": "UoLWhiF+xBB4VRQPlicydbCRDlT0LLwKqZJ6uEkMRQc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000238231"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "疫情短期影响不改创新成长大趋势",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-04-28 00:00:00.000",
      "infoCode": "AP202004281378861800",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 690,
      "attachPages": 4,
      "encodeUrl": "UoLWhiF+xBB4VRQPlicydbSte2PERxPEH9vchaFoC8M=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，疫情背景下稳健增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2020-04-28 00:00:00.000",
      "infoCode": "AP202004281378826356",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321135.王麟"
      ],
      "indvIsNew": "001",
      "researcher": "王麟",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 497,
      "attachPages": 4,
      "encodeUrl": "UoLWhiF+xBB4VRQPlicydSHx4Olm6evsFZJKEaYucBk=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321135"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药公司深度：历久弥新，王者风范",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-03-25 00:00:00.000",
      "infoCode": "AP202003251376919326",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 2688,
      "attachPages": 62,
      "encodeUrl": "Do2v+A0sk2MkDpPfgUU9LHdMaBkBuzyISqU+IPW6RYk=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000238231"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "年报点评：研发创新稳步推进，业绩快速增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2020-03-25 00:00:00.000",
      "infoCode": "AP202003251376911543",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 500,
      "attachPages": 3,
      "encodeUrl": "Do2v+A0sk2MkDpPfgUU9LPFqIky+pvBlsX12zogKNYs=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000177532"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药快速放量，业绩高增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2020-03-24 00:00:00.000",
      "infoCode": "AP202003241376866373",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 687,
      "attachPages": 5,
      "encodeUrl": "sFbLAHrYrIJTpTVh83qIdx2nn/dtIX0IYuyWh5oY8mA=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2019年年报点评：业绩符合预期，创新成果兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2020-03-24 00:00:00.000",
      "infoCode": "AP202003241376865303",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000294535.仰佳佳"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,仰佳佳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 605,
      "attachPages": 5,
      "encodeUrl": "sFbLAHrYrIJTpTVh83qId914inNmIzUJkmTVEoS9t6c=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000294535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩略超预期，肿瘤、造影板块带动业绩增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-03-23 00:00:00.000",
      "infoCode": "AP202003231376835828",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭"
      ],
      "indvIsNew": "001",
      "researcher": "全铭",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 651,
      "attachPages": 6,
      "encodeUrl": "oYVI12G6lp1HQ+hTXwiec07Lf082kcXES84jQ2arPwc=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩略超预期，研发投入再创新高",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-03-23 00:00:00.000",
      "infoCode": "AP202003231376809594",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000203422.周新明",
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "周新明,王睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 382,
      "attachPages": 5,
      "encodeUrl": "oYVI12G6lp1HQ+hTXwiec3tiKeWB6Exvmm5MLbZ2MvM=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000203422",
        "11000308731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新已成核心驱动力，研发投入再创新高",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-03-23 00:00:00.000",
      "infoCode": "AP202003231376807717",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 702,
      "attachPages": 4,
      "encodeUrl": "oYVI12G6lp1HQ+hTXwiec/lvw3CyppCIXhzZOk8A8VI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，创新药持续放量增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2020-03-23 00:00:00.000",
      "infoCode": "AP202003231376799097",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321135.王麟"
      ],
      "indvIsNew": "001",
      "researcher": "王麟",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 456,
      "attachPages": 4,
      "encodeUrl": "oYVI12G6lp1HQ+hTXwiec6vamVBV7sUWf7UxH73MrYs=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000321135"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "获批肝癌适应症，多个适应症有望1-2年上市",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-03-13 00:00:00.000",
      "infoCode": "AP202003131376261521",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1800000000",
      "predictLastYearPe": "72.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭"
      ],
      "indvIsNew": "001",
      "researcher": "全铭",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 564,
      "attachPages": 7,
      "encodeUrl": "R3iJIhFEC1b0tQELDsi1lB38BH1G4U7QBR7nPygrtQY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "SHR1210肝癌二线获批，国内肝癌首个PD（L）1",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2020-03-05 00:00:00.000",
      "infoCode": "AP202003051375880819",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1910000000",
      "predictLastYearPe": "73.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 996,
      "attachPages": 4,
      "encodeUrl": "ywJ6buvFD9v6B2BW/YLxvHB8W6U6vijG6oX/2SNfN5M=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "瑞马唑仑获批，麻醉线再获大品种",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-01-05 00:00:00.000",
      "infoCode": "AP202001051373514881",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.2200000000",
      "predictLastYearPe": "72.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1111,
      "attachPages": 4,
      "encodeUrl": "ZehaCC97ZEH7qFk9Y1izQj1twJqE0YE9e68foPLE8kc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "布局眼科领域，积极拓展产品研发多元化",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-11-10 00:00:00.000",
      "infoCode": "AP201911101370608842",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 702,
      "attachPages": 4,
      "encodeUrl": "+2pAPLNWVshVyNZtBE6tp+ypseoJpYrsN393Lz7N1HQ=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "稀缺的医药创新王者",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-11-01 00:00:00.000",
      "infoCode": "AP201911011370152299",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 5357,
      "attachPages": 102,
      "encodeUrl": "IOqQT73CajCbuS05PCmOlioT+cpx6f+RWLD8ppKFTUU=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药助力高增长，研发投入再创新高",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369867408",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 762,
      "attachPages": 5,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+mQNn/ow9Hy6zV4M7aC6gfo=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "三季报跟踪：Q3收入提速明显，创新龙头未来可期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369859484",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000290731.佘宇"
      ],
      "indvIsNew": "001",
      "researcher": "佘宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 863,
      "attachPages": 9,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+jGb1EYDd8q6+DbJEWlMV60=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000290731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新推动成长加速，研发投入持续创新高",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-10-28 00:00:00.000",
      "infoCode": "AP201910281369849537",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 827,
      "attachPages": 4,
      "encodeUrl": "wquI0aMUC/Lu9O07WkZN+j3t0Ouo/XnYtve6G+dYCIA=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000250544",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩超预期，收入环比加速业绩优异",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2019-10-25 00:00:00.000",
      "infoCode": "AP201910251369775530",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1157,
      "attachPages": 4,
      "encodeUrl": "SAHNyde+EUFGuoPdWD9YHdOu5lvlzmW+zG9WDQJwdlE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩超预期，研发持续高投入",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2019-10-25 00:00:00.000",
      "infoCode": "AP201910251369772973",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000203422.周新明",
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "周新明,王睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 327,
      "attachPages": 5,
      "encodeUrl": "SAHNyde+EUFGuoPdWD9YHZeQjYF4Hd0rR5wsUX2tnrM=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000203422",
        "11000308731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "PD-1等新产品快速放量，加大研发投入，收入增速超预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-10-25 00:00:00.000",
      "infoCode": "AP201910251369749032",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 427,
      "attachPages": 3,
      "encodeUrl": "SAHNyde+EUFGuoPdWD9YHeE092ETFDvyvJZiVknBbYw=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞中报点评：研发投入不断加码，创新布局版图逐步清晰",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80174696",
      "orgName": "莫尼塔投资",
      "orgSName": "莫尼塔投资",
      "publishDate": "2019-09-04 00:00:00.000",
      "infoCode": "AP201909041348461483",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000250128.张静含",
        "11000294535.仰佳佳"
      ],
      "indvIsNew": "001",
      "researcher": "张静含,仰佳佳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 576,
      "attachPages": 7,
      "encodeUrl": "Oeq2e/Jzm17fjZqnRGb+ywU19R2kXQnD7RB4RbAWgw8=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": [
        "11000250128",
        "11000294535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2019年中报点评：分线改革提升销售水平，创新成果拉动业绩增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80114781",
      "orgName": "东兴证券股份有限公司",
      "orgSName": "东兴证券",
      "publishDate": "2019-09-02 00:00:00.000",
      "infoCode": "AP201909021345559002",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000176797.胡博新",
        "11000303836.许睿"
      ],
      "indvIsNew": "001",
      "researcher": "胡博新,许睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 776,
      "attachPages": 5,
      "encodeUrl": "3DsLGJZWbh8phvDvfdNHnmtZ9n4gVrmzwiJHFB3Anio=",
      "sRatingName": "推荐",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000176797",
        "11000303836"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "中报业绩符合预期，四大业务线总体增长良好",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2019-09-02 00:00:00.000",
      "infoCode": "AP201909021345499860",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000203422.周新明",
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "周新明,王睿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 844,
      "attachPages": 6,
      "encodeUrl": "3DsLGJZWbh8phvDvfdNHnksvS0AZ58RrYKbP71iVjT0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000203422",
        "11000308731"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "肿瘤管线高增长，业绩符合预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000049",
      "orgName": "华鑫证券有限责任公司",
      "orgSName": "华鑫证券",
      "publishDate": "2019-08-30 00:00:00.000",
      "infoCode": "AP201908301345419141",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000259031.杜永宏"
      ],
      "indvIsNew": "001",
      "researcher": "杜永宏",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 799,
      "attachPages": 5,
      "encodeUrl": "OVxikYD4eFD+OqSE75vIZhkCjqXhEHpQw7UYGrE3oHo=",
      "sRatingName": "推荐",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000259031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2019年半年报点评：收入增长持续加速，研发投入持续大幅增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-08-30 00:00:00.000",
      "infoCode": "AP201908301345379785",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000250544.陈铁林",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈铁林,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 824,
      "attachPages": 4,
      "encodeUrl": "OVxikYD4eFD+OqSE75vIZiFQhVWOIyIOCtpxgcLT5s0=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000250544",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "新品种逐步放量，研发投入力度加大，业绩符合预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-08-30 00:00:00.000",
      "infoCode": "AP201908301345377501",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 431,
      "attachPages": 3,
      "encodeUrl": "OVxikYD4eFD+OqSE75vIZg+pLgJ0jUGLYXDcXpDiVXY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "公司业绩符合预期，PD-1临床进展超预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2019-08-30 00:00:00.000",
      "infoCode": "AP201908301345373059",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000172706.李敬雷"
      ],
      "indvIsNew": "001",
      "researcher": "李敬雷",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 985,
      "attachPages": 4,
      "encodeUrl": "OVxikYD4eFD+OqSE75vIZgnqrh6BvGAq1tx/fm9imVM=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000172706"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药中报点评：业绩符合预期，新产品快速放量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80045894",
      "orgName": "新时代证券股份有限公司",
      "orgSName": "新时代证券",
      "publishDate": "2019-08-30 00:00:00.000",
      "infoCode": "AP201908301345373029",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000178543.崔文亮",
        "11000307533.王帅"
      ],
      "indvIsNew": "001",
      "researcher": "崔文亮,王帅",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 420,
      "attachPages": 4,
      "encodeUrl": "OVxikYD4eFD+OqSE75vIZiykTJpuEhDaDDxHjTKvXmQ=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000178543",
        "11000307533"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药深度报告：定位中国制药创新未来",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80045894",
      "orgName": "新时代证券股份有限公司",
      "orgSName": "新时代证券",
      "publishDate": "2019-08-22 00:00:00.000",
      "infoCode": "AP201908221344895901",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.2100000000",
      "predictLastYearPe": "59.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000178543.崔文亮",
        "11000307533.王帅"
      ],
      "indvIsNew": "001",
      "researcher": "崔文亮,王帅",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 6588,
      "attachPages": 80,
      "encodeUrl": "eQqgb6rkfBcz5eW8XrSVN5k3nApX9c4V68PAE+/RGhU=",
      "sRatingName": "强烈推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000178543",
        "11000307533"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "PD-1联合FOLFOX4一线治疗晚期肝细胞获批III临床，适应症拓展提升产品潜力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-07-17 00:00:00.000",
      "infoCode": "AP201907171339160069",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 461,
      "attachPages": 4,
      "encodeUrl": "nw1I6XgU4nePsLJEMUU/FfUvC85pyny8rmfuBrDmvB4=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "抗肿瘤重磅首仿获批，持续完善肿瘤产品",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-07-11 00:00:00.000",
      "infoCode": "AP201907111338427100",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 831,
      "attachPages": 4,
      "encodeUrl": "yyJwpCJWGoe0OWluSsJdo3Y2bBdWc1DI+3eIuen42qg=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "PD-1食管鳞癌III期临床结果优异，阿比特龙首仿上市，仿创结合持续推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-07-09 00:00:00.000",
      "infoCode": "AP201907091338198174",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 444,
      "attachPages": 4,
      "encodeUrl": "FQrx4x/DseEVQMnv8FoQchc4UPIFB4F0c1JJJpFyMh4=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "超级重磅PD-1单抗获批，成长最强动力就位",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2019-06-03 00:00:00.000",
      "infoCode": "AP201906031333397109",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000259464.陈进"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,陈进",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 829,
      "attachPages": 4,
      "encodeUrl": "XcUwiZpu4fya7eMh7BUBDv/yuzrtc8O5BQe0htAF2aM=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764",
        "11000259464"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "卡瑞丽珠获批上市，加快公司创新产品线布局",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-06-03 00:00:00.000",
      "infoCode": "AP201906031333392582",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 801,
      "attachPages": 8,
      "encodeUrl": "XcUwiZpu4fya7eMh7BUBDu8qeLsfO9mo9przvq9MNNQ=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "仿创结合+制剂出口奠基础，创新药龙头拔锚启航开新章",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2019-05-29 00:00:00.000",
      "infoCode": "AP201905291332781363",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1800000000",
      "predictLastYearPe": "53.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭",
        "11000246735.焦德智",
        "11000255331.许汪洋"
      ],
      "indvIsNew": "001",
      "researcher": "全铭,焦德智,许汪洋",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 4466,
      "attachPages": 50,
      "encodeUrl": "nGUEB6+J1+hVnUHLgFLb/fh6oQgwyqQYj3kGs7SXjTg=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000247525",
        "11000246735",
        "11000255331"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2019年一季报点评：增速符合预期，PD-1单抗上市在即",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2019-04-22 00:00:00.000",
      "infoCode": "AP201904221321246153",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 0,
      "reportType": 2,
      "author": [
        "11000252431.卢立亭",
        "11000271131.刘佳"
      ],
      "indvIsNew": "001",
      "researcher": "卢立亭,刘佳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 590,
      "attachPages": 3,
      "encodeUrl": "8cI+B30FcqluFHdX7UDC22+c7zl5xg9ye1hryCWG8xc=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252431",
        "11000271131"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "一季报跟踪：业绩保持稳健较快增长，研发投入持续加大",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2019-04-19 00:00:00.000",
      "infoCode": "AP201904191320877661",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000277542.王晓琦"
      ],
      "indvIsNew": "001",
      "researcher": "王晓琦",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 638,
      "attachPages": 8,
      "encodeUrl": "fP5ylMpdQqwfI8YNzjX6sCZh33NscEctNpAPTyCzLYc=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000277542"
      ],
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 4,
  "currentYear": 2025
}